or Try an Advanced Search...

    Technical Analysis for ADTX - ADiTx Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 1.58 15.33% 0.21
    ADTX closed up 15.33 percent on Monday, July 1, 2024, on 7.03 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Up
    Historical ADTX trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    MACD Bullish Signal Line Cross Bullish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Volume Surge Other 0.00%
    Wide Range Bar Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 15.33%
    Older End-of-Day Signals for ADTX ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 8 hours ago
    Rose Above 10 DMA about 8 hours ago
    2x Volume Pace about 8 hours ago
    1.5x Volume Pace about 8 hours ago
    3x Volume Pace about 8 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ADTX Chart by TradingView
    Basic chart:

    Profile

    Aditx Therapeutics, Inc., is developing technologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring. The immune reprogramming technology is currently at the pre-clinical stage and is designed to retrain the immune system to induce tolerance with an objective of addressing rejection of transplanted organs, autoimmune diseases, and allergies. The immune monitoring technology is designed to provide a personalized comprehensive profile of the immune system.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Immunology Immune System Immunotherapy Autoimmune Disease Autoimmunity Organs Allergies

    Is ADTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 2 Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Apr 2 Aditxt signs agreement to acquire Appili Therapeutics
    Apr 2 Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)
    Mar 27 Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023
    Mar 7 For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy
    Feb 1 Evofem Biosciences achieves 2023 prelim net product sales of $18.1M to $18.3M
    Feb 1 Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023
    Jan 30 Aditxt buys Brain Scientific's portfolio of EEG brain monitoring technologies and devices
    Jan 30 Aditxt, Inc. Acquires Proprietary Electroencephalography (EEG) Brain Monitoring Technologies and Devices, Including NeuroCap™ and NeuroEEG™ for Telehealth and Tele-neurology Applications
    Jan 18 Aditxt files to sell 3.79M shares for holders
    See more ADTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 68.08
    52 Week Low 1.35
    Average Volume 40,764
    200-Day Moving Average 4.88
    50-Day Moving Average 1.97
    20-Day Moving Average 1.67
    10-Day Moving Average 1.45
    Average True Range 0.13
    RSI (14) 41.52
    ADX 31.39
    +DI 20.65
    -DI 23.83
    Chandelier Exit (Long, 3 ATRs) 1.61
    Chandelier Exit (Short, 3 ATRs) 1.75
    Upper Bollinger Bands 2.15
    Lower Bollinger Band 1.19
    Percent B (%b) 0.41
    BandWidth 57.60
    MACD Line -0.18
    MACD Signal Line -0.19
    MACD Histogram 0.0045
    Fundamentals Value
    Market Cap 2.63 Million
    Num Shares 1.67 Million
    EPS -12.00
    Price-to-Earnings (P/E) Ratio -0.13
    Price-to-Sales 8.56
    Price-to-Book 0.38
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.02
    Resistance 3 (R3) 2.00 1.83 1.94
    Resistance 2 (R2) 1.83 1.72 1.84 1.92
    Resistance 1 (R1) 1.71 1.65 1.77 1.73 1.90
    Pivot Point 1.54 1.54 1.57 1.55 1.54
    Support 1 (S1) 1.42 1.43 1.48 1.43 1.26
    Support 2 (S2) 1.25 1.36 1.26 1.24
    Support 3 (S3) 1.12 1.25 1.22
    Support 4 (S4) 1.14